-+ 0.00%
-+ 0.00%
-+ 0.00%

ELEVAR THERAPEUTICS RECEIVES FDA CONDITIONAL ACCEPTANCE OF LYRFIGTU AS BRAND NAME FOR LIRAFUGRATINIB

路透·09/22/2026 12:31:53

请登录查看新闻详情